DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Arthur Klausner will be a panelist at the New York Biotechnology Association’s Annual Meeting
News | 04. 17. 2006
© 2020 Pappas Capital, LLC. ALL RIGHTS RESERVED.